Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples